Saleamlak Sebsibe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saleamlak Sebsibe has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Afewerk Habtamu
School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
5 shared publications - Sisay Desale
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
5 shared publications - Mikiyas Shemelis Achame
School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
4 shared publications - Mahider Shimelis Feyisa
School of Medical Laboratory Sciences, Asrat Weldeyes Health Science Campus Debre Berhan University Debre Berhan Ethiopia
3 shared publications - Yonas Erkihun
School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
3 shared publications - Zewudu Mulatie
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie Ethiopia
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in BMC Pediatrics
Effect of phototherapy on serum electrolyte levels among neonates with hyperbilirubinemia: a systematic review and meta-analysis
- 18 November 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessEffect of phototherapy on serum electrolyte levels among neonates with hyperbilirubinemia: a systematic review and meta-analysis
- Open Access
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73354
Blood Unit Discard Rates Due to Transfusion–Transmissible Infections and Non‐Infectious Causes and Their Associated Factors in Eastern and Northeastern Parts of Amhara Regional State, Ethiopia: A Retrospective Cross‐Sectional Study From 2022–2025
Background: Blood is an irreplaceable medical resource, yet blood unit discard remains a significant challenge for transfusion services. This study aimed to evaluate discard rates by integrating both infectious (TTI) and non‐infectious causes and identifying factors associated with blood wastage to provide evidence to support strategies for improving blood safety. Methods: An institutional‐based retrospective cross‐sectional study was conducted using data from 2022 to 2025 across Dessie, Kemise, Woldia, and Sekota Blood Banks. Data were extracted from Blood Bank databases using a structured checklist and analyzed with SPSS version 26.0. Both univariable and Multivariable logistic regression were performed to identify predictors of transfusion transmissible infections (TTIs) and non‐infectious causes, with statistical significance set at p < 0.05. Results: Records from 60,008 donors and 67,976 blood products were reviewed. A total of 6,130 units (9.02%) were discarded. TTIs accounted for 4.6% of discards, led by Hepatitis B virus (2.0%) and Syphilis (1.2%). Non‐infectious causes contributed 4.4%, primarily due to expiration (2.0%). ABO group, Rh factor, donor age, donor type, collection site, and Blood Bank location were identified as significant predictors of discard. Conclusion: The study reveals a notable blood unit discard rate of 9.02%, driven equally by infectious transfusion‐transmissible infections and non‐infectious factors like expiration. Key risk factors include donor demographics, blood group, and specific blood bank locations, highlighting the need for better inventory management and targeted donor selection.
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73354
Open AccessBlood Unit Discard Rates Due to Transfusion–Transmissible Infections and Non‐Infectious Causes and Their Associated Factors in Eastern and Northeastern Parts of Amhara Regional State, Ethiopia: A Retrospective Cross‐Sectional Study From 2022–2025
Background: Blood is an irreplaceable medical resource, yet blood unit discard remains a significant challenge for transfusion services. This study aimed to evaluate discard rates by integrating both infectious (TTI) and non‐infectious causes and identifying factors associated with blood wastage to provide evidence to support strategies for improving blood safety. Methods: An institutional‐based retrospective cross‐sectional study was conducted using data from 2022 to 2025 across Dessie, Kemise, Woldia, and Sekota Blood Banks. Data were extracted from Blood Bank databases using a structured checklist and analyzed with SPSS version 26.0. Both univariable and Multivariable logistic regression were performed to identify predictors of transfusion transmissible infections (TTIs) and non‐infectious causes, with statistical significance set at p < 0.05. Results: Records from 60,008 donors and 67,976 blood products were reviewed. A total of 6,130 units (9.02%) were discarded. TTIs accounted for 4.6% of discards, led by Hepatitis B virus (2.0%) and Syphilis (1.2%). Non‐infectious causes contributed 4.4%, primarily due to expiration (2.0%). ABO group, Rh factor, donor age, donor type, collection site, and Blood Bank location were identified as significant predictors of discard. Conclusion: The study reveals a notable blood unit discard rate of 9.02%, driven equally by infectious transfusion‐transmissible infections and non‐infectious factors like expiration. Key risk factors include donor demographics, blood group, and specific blood bank locations, highlighting the need for better inventory management and targeted donor selection.
- Open Access
- 1 October 2026
- Published by Springer Nature in BMC Women's Health
Molecular epidemiology of cervical high-risk human papillomavirus infection in Ethiopia (2000–2026): a systematic review and meta-analysis
- 1 October 2026
- Published by Springer Nature in BMC Women's Health
Open AccessMolecular epidemiology of cervical high-risk human papillomavirus infection in Ethiopia (2000–2026): a systematic review and meta-analysis
- Open Access
- 9 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Burden of Epstein-Barr virus in gastric cancer, nasopharyngeal carcinoma, and Burkitt lymphoma in Africa: a systematic review and meta-analysis
Epstein-Barr virus (EBV) is implicated in nasopharyngeal carcinoma (NPC), gastric cancer (GC), and Burkitt lymphoma (BL), but its burden across Africa rema
- 9 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessBurden of Epstein-Barr virus in gastric cancer, nasopharyngeal carcinoma, and Burkitt lymphoma in Africa: a systematic review and meta-analysis
Epstein-Barr virus (EBV) is implicated in nasopharyngeal carcinoma (NPC), gastric cancer (GC), and Burkitt lymphoma (BL), but its burden across Africa rema
- Open Access
- 2 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Prevalence of Staphylococcus aureus among food handlers in Ethiopia, 2000–2024: a systematic review and meta-analysis
Staphylococcal foodborne illness is a prevalent global foodborne disease caused by the ingestion of food contaminated with Staphylococcus aureus enterotoxi
- 2 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessPrevalence of Staphylococcus aureus among food handlers in Ethiopia, 2000–2024: a systematic review and meta-analysis
Staphylococcal foodborne illness is a prevalent global foodborne disease caused by the ingestion of food contaminated with Staphylococcus aureus enterotoxi
- Open Access
- 29 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-14
Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study
Human papillomavirus is the most widespread sexually transmitted virus. At least 14 HPV genotypes have been defined as high-risk human papillomavirus types. HPV types 16 and 18 are the two most common high-risk types, contributing to 70% of cervical cancer. The persistence of high-risk HPV infection is linked with weakened immunity. This study aims to determine the molecular epidemiology of high-risk cervical human papillomavirus infection and associated factors among women living with HIV attending public health facilities in Dessie and Kombolcha cities, northeast Ethiopia. A facility-based cross-sectional study was employed from May to July 2024 at public health facility antiretroviral clinics in Dessie and Kombolcha cities, involving 386 women living with HIV. Participants were recruited using systematic random sampling. Socio-demographic and clinical data were collected using semi-structured questionnaires. Cervical swab samples were collected using Abbott cervi-collect specimen collection kit and high-risk HPV analyzed using real-time DNA polymerase chain reaction with the Abbott molecular system. The data were analyzed with SPSS version 26.0. Logistic regression analysis was utilized to identify associated factors, and then variables with a p-value ≤ 0.05 were considered as statistically significant. The overall prevalence of hrHPV infections among study participants was 28.8% [111/386, (95% CI: 24.9, 33.2). The frequently detected genotypes were HPV 16 (27%), HPV 18 (15.3%), and non-16/18 hrHPV (47.7%). In multivariable analysis, the factors independently associated with hrHPV were the number of lifetime sexual partners ≥ 3 (AOR = 2.58, 95% CI: 1.34, 4.99), failure to use a condom during sex (AOR = 1.99, 95% CI: 1.18, 3.34), history of sexually transmitted infections (AOR = 2.12, 95% CI: 1.24, 3.62), duration of Antiretroviral Treatment (ART) < 2 years (AOR = 2.88, 95% CI: 1.61, 5.16), CD4 count < 350/mm3 (AOR = 2.35, 95% CI: 1.34, 4.12), and HIV viral load > 50 copies/ml (AOR = 2.97, 95% CI: 1.70, 5.20). The study revealed a significantly higher prevalence of hrHPV among HIV-positive women in Dessie and Kombolcha cities. The non-16/18 hrHPV genotype was the more frequent compared to HPV 16 and 18. Predictive factors for hrHPV infection included multiple sexual partners, non-use of condoms, history of sexually transmitted infections, short duration on ART, low CD4 counts, and high viral loads. To reduce this risk, ART programs should incorporate cervical cancer screening, promote HPV vaccination, and strengthen sexual health education.
- 29 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-14
Open AccessMolecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study
Human papillomavirus is the most widespread sexually transmitted virus. At least 14 HPV genotypes have been defined as high-risk human papillomavirus types. HPV types 16 and 18 are the two most common high-risk types, contributing to 70% of cervical cancer. The persistence of high-risk HPV infection is linked with weakened immunity. This study aims to determine the molecular epidemiology of high-risk cervical human papillomavirus infection and associated factors among women living with HIV attending public health facilities in Dessie and Kombolcha cities, northeast Ethiopia. A facility-based cross-sectional study was employed from May to July 2024 at public health facility antiretroviral clinics in Dessie and Kombolcha cities, involving 386 women living with HIV. Participants were recruited using systematic random sampling. Socio-demographic and clinical data were collected using semi-structured questionnaires. Cervical swab samples were collected using Abbott cervi-collect specimen collection kit and high-risk HPV analyzed using real-time DNA polymerase chain reaction with the Abbott molecular system. The data were analyzed with SPSS version 26.0. Logistic regression analysis was utilized to identify associated factors, and then variables with a p-value ≤ 0.05 were considered as statistically significant. The overall prevalence of hrHPV infections among study participants was 28.8% [111/386, (95% CI: 24.9, 33.2). The frequently detected genotypes were HPV 16 (27%), HPV 18 (15.3%), and non-16/18 hrHPV (47.7%). In multivariable analysis, the factors independently associated with hrHPV were the number of lifetime sexual partners ≥ 3 (AOR = 2.58, 95% CI: 1.34, 4.99), failure to use a condom during sex (AOR = 1.99, 95% CI: 1.18, 3.34), history of sexually transmitted infections (AOR = 2.12, 95% CI: 1.24, 3.62), duration of Antiretroviral Treatment (ART) < 2 years (AOR = 2.88, 95% CI: 1.61, 5.16), CD4 count < 350/mm3 (AOR = 2.35, 95% CI: 1.34, 4.12), and HIV viral load > 50 copies/ml (AOR = 2.97, 95% CI: 1.70, 5.20). The study revealed a significantly higher prevalence of hrHPV among HIV-positive women in Dessie and Kombolcha cities. The non-16/18 hrHPV genotype was the more frequent compared to HPV 16 and 18. Predictive factors for hrHPV infection included multiple sexual partners, non-use of condoms, history of sexually transmitted infections, short duration on ART, low CD4 counts, and high viral loads. To reduce this risk, ART programs should incorporate cervical cancer screening, promote HPV vaccination, and strengthen sexual health education.